Item 16. FORM 10-K SUMMARY
5K characters. Original on sec.gov ·
Item 16. FORM 10-K SUMMARY
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Pleasanton, State of California, on this 6th day of March, 2026.
| WORKDAY, INC. | |||||
| /s/ Zane Rowe | |||||
| Zane Rowe Chief Financial Officer (Principal Financial Officer) | |||||
| /s/ Mark Garfield | |||||
| Mark Garfield Chief Accounting Officer (Principal Accounting Officer) |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Zane Rowe or Richard H. Sauer, or any of them, his or her attorneys-in-fact, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ Aneel Bhusri | Chief Executive Officer and Director | March 6, 2026 | ||||||||||||
| Aneel Bhusri | (Principal Executive Officer) | |||||||||||||
| /s/ Zane Rowe | Chief Financial Officer | March 6, 2026 | ||||||||||||
| Zane Rowe | (Principal Financial Officer) | |||||||||||||
| /s/ Mark Garfield | Chief Accounting Officer | March 6, 2026 | ||||||||||||
| Mark Garfield | (Principal Accounting Officer) | |||||||||||||
| /s/ Thomas F. Bogan | Director | March 6, 2026 | ||||||||||||
| Thomas F. Bogan | ||||||||||||||
| /s/ Elizabeth Centoni | Director | March 6, 2026 | ||||||||||||
| Elizabeth Centoni | ||||||||||||||
| /s/ Lynne M. Doughtie | Director | March 6, 2026 | ||||||||||||
| Lynne M. Doughtie | ||||||||||||||
| /s/ Wayne A.I. Frederick, M.D | Director | March 6, 2026 | ||||||||||||
| Wayne A.I. Frederick, M.D | ||||||||||||||
| /s/ Mark J. Hawkins | Director | March 6, 2026 | ||||||||||||
| Mark J. Hawkins | ||||||||||||||
| /s/ Michael M. McNamara | Director | March 6, 2026 | ||||||||||||
| Michael M. McNamara | ||||||||||||||
| /s/ Rhonda J. Morris | Director | March 6, 2026 | ||||||||||||
| Rhonda J. Morris | ||||||||||||||
| /s/ Michael L. Speiser | Director | March 6, 2026 | ||||||||||||
| Michael L. Speiser | ||||||||||||||
| /s/ George J. Still, Jr. | Director | March 6, 2026 | ||||||||||||
| George J. Still, Jr. | ||||||||||||||
| /s/ Jerry Yang | Director | March 6, 2026 | ||||||||||||
| Jerry Yang |
Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES